Home 8-Amino-7-(aryl/hetaryl)fluoroquinolones. An emerging set of synthetic antibacterial agents
Article
Licensed
Unlicensed Requires Authentication

8-Amino-7-(aryl/hetaryl)fluoroquinolones. An emerging set of synthetic antibacterial agents

  • Ala’a A. Al-Akhras , Jalal A. Zahra EMAIL logo , Mustafa M. El-Abadelah EMAIL logo , Lubna F. Abu-Niaaj and Monther A. Khanfar
Published/Copyright: October 21, 2022
Become an author with De Gruyter Brill

Abstract

This study reports the synthesis of seven new 8-amino-7-(aryl/hetaryl)fluoroquinolones and their antibacterial activity against 10 bacteria associated with microbial infections and foodborne illnesses. These fluoroquinolones are prepared via the reactions of selected aryl(hetaryl)boronic acids with ethyl-7chloro-6-fluoro-8-nitroquinolone-3-carboxylate, under Suzuki–Miyaura cross-coupling conditions. Nitro group reduction of the latter resulted in the corresponding 8-aminoquinolone-3-esters which upon hydrolysis formed the respective 8-amino-7-(aryl/hetaryl)-quinolone-3-carboxylic acids. The latter compounds were tested against selected Gram-negative bacteria (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumonia) and Gram-positive bacteria (Enterococcus feacalis, Listeria monocytogenes, Streptococcus agalactiae, Staphylococcus epidermidis, and Staphylococcus aureus). The tested fluoroquinolones showed a significant antimicrobial activity against most of the tested bacterial strains. The antimicrobial activity of some of the tested compounds were comparable to or higher than a wide range of standard antibiotics including ampicillin, ciprofloxacin, and imipenem. The results highlight the new synthesized 8-amino-7-(aryl/hetaryl)fluroquinolones as promising candidates for new antimicrobial drugs to treat bacterial infections. This study highlights that the newly synthetic 8-amino-7-(aryl/hetaryl)fluroquinolones are promising candidates for new antimicrobial drugs to treat human diseases including foodborne illnesses.


Corresponding author: Jalal A. Zahra and Mustafa M. El-Abadelah, Chemistry Department, Faculty of Science, The University of Jordan, Amman, 11942, Jordan, E-mail: ,

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: We thank the Abdul Hameed Shoman Foundation for financial support (Grant number 5/2020).

  3. Conflict of interest statement: The authors declare to conflicts of interest regarding this article.

References

1. Yanshu, JA, Liyan, Z. The antibacterial activity of fluoroquinolone derivatives: an update (2018e2021). Eur J Med Chem 2021;224:113741.10.1016/j.ejmech.2021.113741Search in Google Scholar PubMed

2. Ezelarab, HA, Abbas, SH, Hassan, HA, Abuo-Rahma, GEDA. Recent updates of fluoroquinolones as antibacterial agents. Arch Pharmazie 2018;351:1800141. ‏https://doi.org/10.1002/ardp.201800141.Search in Google Scholar PubMed

3. Pham, TD, Ziora, ZM, Blaskovich, MA. Quinolone antibiotics. Medchemcomm 2019;10:1719–39. ‏. https://doi.org/10.1039/c9md00120d.Search in Google Scholar PubMed PubMed Central

4. Wagman, AS, Wentland, MP. In: Taylor, JB, Triggle, DJ, editors. Comprehensive Medicinal Chemistry II. Oxford: Elsevier Ltd; 2007, vol 7:567–96 pp.10.1016/B0-08-045044-X/00220-0Search in Google Scholar

5. Matada, BS, Pattanashettar, R, Yernale, NG. A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg Med Chem 2021;32:115973. https://doi.org/10.1016/j.bmc.2020.115973.Search in Google Scholar PubMed

6. Bush, NG, Diez-Santos, I, Abbott, LR, Maxwell, A. Quinolones: mechanism, lethality and their contributions to antibiotic resistance. Molecules 2020;25:5662. https://doi.org/10.3390/molecules25235662.Search in Google Scholar PubMed PubMed Central

7. Hiasa, H. DNA Topoisomerases as targets for antibacterial agents. In: Drolet, M, editor. DNA topoisomerases. Methods in molecular biology. New York, NY: Humana Press; 2018, vol 1703:47–62 pp.10.1007/978-1-4939-7459-7_3Search in Google Scholar PubMed

8. Gootz, TD, Brighty, KE. In: Andriole, VT, editor The quinolones, 2nd ed. San Diego: Academic Press; 1998:29 p.Search in Google Scholar

9. Jiang, D. 4-Quinolone derivatives and their activities against gram-negative pathogens. J Heterocycl Chem 2018;55:2003–18. https://doi.org/10.1002/jhet.3244.Search in Google Scholar

10. Xu, J-H, Fan, Y-L, Zhou, J. Quinolone–triazole hybrids and their biological activities. J Heterocycl Chem 2018;55:1854–62. https://doi.org/10.1002/jhet.3234.Search in Google Scholar

11. Wright, DH, Brown, GH, Peterson, ML, Rotschafer, JC. Application of fluoroquinolone pharmacodynamics. J Antimicrob Chemother 2000;46:669–83. https://doi.org/10.1093/jac/46.5.669.Search in Google Scholar PubMed

12. Hu, YQ, Zhang, S, Xu, Z, Lv, ZS, Liu, ML, Feng, LS. 4-Quinolone hybrids and their antibacterial activities. Eur J Med Chem 2017;141:335–45. https://doi.org/10.1016/j.ejmech.2017.09.050.Search in Google Scholar PubMed

13. Castro, W, Navarro, M, Boit, C. Medicinal potential of ciprofloxacin and its derivatives. Future Med Chem 2013;5:81–96. https://doi.org/10.4155/fmc.12.181.Search in Google Scholar PubMed

14. Akhtar, R, Yousaf, M, Naqvi, SAR, Irfan, M, Zahoor, AF, Hussain, AI, et al.. Synthesis of ciprofloxacin-based compounds: a review. Synth Commun 2016;26:1849–97. https://doi.org/10.1080/00397911.2016.1234622.Search in Google Scholar

15. Zhang, GF, Liu, X, Zhang, S, Pan, B, Liu, ML. Ciprofloxacin derivatives and their antibacterial activities. Eur J Med Chem 2018;146:599–612. https://doi.org/10.1016/j.ejmech.2018.01.078.Search in Google Scholar PubMed

16. Al-Trawneh, SA, El-Abadelah, MM, Al-Abadleh, MM, Zani, F, Incerti, M, Vicini, P. A new efficient route to 7-aryl-6-fluoro-8-nitroquinolones as potent antibacterial agents. Eur J Med Chem 2014;86:364–7. https://doi.org/10.1016/j.ejmech.2014.08.065.Search in Google Scholar PubMed

17. Pulla, RM, Venkaiah, CN. An improved process for the preparation of quinolone derivatives, e.g. Ciprofloxacin. PTC Int Appl W0 085 692 2001. (Chem Abstr 2001;135:3716 49).Search in Google Scholar

18. Sanchez, JP, Domagala, JM, Hagen, SE, Heifetz, CL, Hutt, MP, Nichols, JB, et al.. Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1, 8-naphthyridine-3-carboxylic acids. J Med Chem 1988;31:983–91. https://doi.org/10.1021/jm00400a016.Search in Google Scholar PubMed

19. Grohe, K, Heitzer, H. Synthese von 4-Chinolon-3-carbonsauren. Liebigs Ann Chem 1987;1987:29–37. https://doi.org/10.1002/jlac.198719870106.Search in Google Scholar

20. Al-Trawneh, SA, Zahra, JA, Kamal, MR, El-Abadelah, MM, Zani, F, Incerti, M, et al.. Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents. Bioorg Med Chem 2010;18:5873–84. https://doi.org/10.1016/j.bmc.2010.06.098.Search in Google Scholar PubMed

21. Stille, JK. The palladium-catalyzed cross-coupling reactions of organotin reagents with organic electrophiles [New synthetic methods (58)]. Angew Chem Int Ed Engl 1986;25:508–24. https://doi.org/10.1002/anie.198605081.Search in Google Scholar

22. Farina, V, Krishnamurphy, V, Scott, WJ. The Stille reaction. Org React 1997;50:1–625.10.1002/0471264180.or050.01Search in Google Scholar

23. Mitchell, TN. In: De Meijere, A, Dederich, F, editors. Organotin Reagents in Cross-Coupling Reactions In: Metal-Catalyzed Cross-Coupling Reactions. Weinheim: Wiley-VCH; 2004, vol 1:125–61 pp.10.1002/9783527619535.ch3Search in Google Scholar

24. Clinical and Laboratory Standard Institute. Performance standard for antibiotic susceptibility testing; 2020. Available from: https://www.nih.org.pk/wp-content/uploads/2021/02/CLSI-2020.pdf.Search in Google Scholar

25. Dolomanov, OV, Bourhis, LJ, Gildea, RJ, Howard, JAK, Puschmann, H. A complete structure solution, refinement and analysis program. J Appl Crystallogr 2009;42:339–41. https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

26. Sheldrick, GM. Integrated space-group and crystal-structure determination. Acta Crystallogr 2015;A71:3–8. https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central

27. Sheldrick, GM. Crystal structure refinement with Shelxl. Acta Crystallogr 2015;C71:3–8. https://doi.org/10.1107/s2053229614024218.Search in Google Scholar PubMed PubMed Central

28. Beletskaya, IP, Alonso, F, Tyurin, V. The Suzuki-Miyaura reaction after the Nobel prize. Coord Chem Rev 2019;385:137–73. https://doi.org/10.1016/j.ccr.2019.01.012.Search in Google Scholar

29. Taheri Kal Koshvandi, A, Heravi, MM, Momeni, T. Current applications of Suzuki–Miyaura coupling reaction in the total synthesis of natural products: an update. Appl Organomet Chem 2018;32: e4210, https://doi.org/10.1002/aoc.4210.Search in Google Scholar

30. Suzuki, A, Brown, HC. Organic syntheses via boranes. Milwaukee, W1: Aldrich Chemical Co Inc; 2003, vol 3.Search in Google Scholar

31. Hassan, J, Sévignov, M, Gozzi, C, Schulz, E, Lemaire, M. Aryl−Aryl bond formation one century after the discovery of the Ullmann reaction. Chem Rev 2002;102:1359–470. https://doi.org/10.1021/cr000664r.Search in Google Scholar PubMed

32. Kotha, S, Lahiri, K, Dhurke, K. Recent applications of the Suzuki–Miyaura cross-coupling reaction in organic synthesis. Tetrahedran 2002;58:9633–95. https://doi.org/10.1016/s0040-4020(02)01188-2.Search in Google Scholar

33. Suzuki, A. Cross-coupling reactions via organoboranes. J Organormet Chem 2002;653:83–90. https://doi.org/10.1016/s0022-328x(02)01269-x.Search in Google Scholar

34. Kadu, BS. Suzuki–Miyaura cross coupling reaction: recent advancements in catalysis and organic synthesis. Catal Sci Technol 2021;11:1186–221. https://doi.org/10.1039/d0cy02059a.Search in Google Scholar

35. D’Alterio, MC, Casals-Cruañas, E, Tzouras, NV, Talarico, G, Nolan, SP, Poater, A. Mechanistic aspects of the palladium-catalyzed Suzuki-Miyaura cross-coupling reaction. Chem Eur J 2021;27:13481–93. https://doi.org/10.1002/chem.202101880.Search in Google Scholar PubMed PubMed Central

36. 36a.Miyaura, N, editor. Cross-coupling reactions. Berlin: Springer-Verlag; 2002.36b.Miyaura, N, Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem Rev 1995;95:2457–83.10.1007/3-540-45313-XSearch in Google Scholar

37. Howard, A, Donoghue, MO, Feeney, A, Sleator, RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 2012;3:243–50. https://doi.org/10.4161/viru.19700.Search in Google Scholar PubMed PubMed Central

38. Taylor, TA. Staphylococcus aureus. StatPearls [Internet]. U.S. National Library of Medicine; 2018.Search in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/znc-2022-0143).


Received: 2022-06-19
Accepted: 2022-09-28
Published Online: 2022-10-21
Published in Print: 2023-03-28

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/znc-2022-0143/pdf
Scroll to top button